MedTrace Logo

Internet-Delivered Cognitive Behaviour Therapy for Women with Perimenopausal Anxiety

NCT06865066 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2025-03-07

No results posted yet for this study

Summary

The goal of this clinical trial is to design an online Cognitive Behavioural Therapy (CBT) and Acceptance Commitment Therapy (ACT) program and to learn if it can treat anxiety in women transitioning into menopause (perimenopause).

The main questions it aims to answer are:

* Is our online psychotherapy program a practical and acceptable means of managing anxiety during perimenopause?
* Does our online psychotherapy program work in improving anxiety levels during perimenopause?

Participants will participate in weekly e-CBT module sessions tailored to perimenopausal anxiety and will be given weekly feedback on assignments from trained care providers through a secure online platform. Participants will complete questionnaires at the beginning, middle, and at end of the study, as well as at the three and six-month follow-up.

Conditions

Interventions

BEHAVIORAL

e-CBT

Electronically delivered cognitive behavioural therapy with acceptance commitment therapy components

Sponsors & Collaborators

  • Dr. Nazanin Alavi

    lead OTHER

Principal Investigators

  • Nazanin Alavi, MD, FRCPC · Queen's University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-11
Primary Completion
2025-02-28
Completion
2025-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06865066 on ClinicalTrials.gov